Human Blood Products for Research: A Complete Guide to Whole Blood, Plasma, Serum, PBMCs, and Biospecimens
Human blood is one of the most information-dense biological materials available for biomedical research. A single blood draw yields not one but many distinct research-grade products — each with different cellular, molecular, and biochemical content, and each suited to different experimental questions. Human whole blood, human plasma, human serum, peripheral blood mononuclear cells (PBMCs), leukapheresis products, and CD34+ progenitor cells are all derived from blood, but they are not interchangeable. Selecting the wrong blood-derived product for a given application is one of the most common and avoidable sources of experimental failure in translational research. This guide covers every major human blood product used in biomedical research — what each product is, what it contains, what it is used for, and how to source qualified specimens that meet the standards demanding research requires.
Human Whole Blood
What Is Human Whole Blood?
Human whole blood is peripheral blood collected from a donor into an anticoagulant-containing tube (EDTA, heparin, or sodium citrate, depending on intended use) with no further processing. It contains every cellular component of blood — red blood cells, platelets, granulocytes, and mononuclear cells — along with the full complement of plasma proteins, clotting factors, hormones, metabolites, and circulating cytokines. It is the most physiologically complete blood-derived research material and the closest in vitro approximation to the in vivo immune environment.
What Is Human Whole Blood Used For?
Human whole blood is used across a broad range of research applications, including:
- Whole blood stimulation assays — Measuring innate and adaptive immune responses under conditions that preserve the contributions of granulocytes, platelets, and plasma factors (e.g., TruCulture, LPS challenge assays)
- Hematology and complete blood count reference panels — Baseline immunophenotyping using lyse-no-wash flow cytometry protocols that require intact whole blood
- Neutrophil and granulocyte function studies — Oxidative burst assays, phagocytosis, and NET formation require the granulocyte populations that are depleted in PBMC isolation
- Platelet-immune interaction research — Studies of thromboinflammation and platelet-leukocyte aggregates
- Nucleic acid extraction — Whole blood collected in PAXgene or Tempus tubes is used as the starting material for RNA and DNA isolation in gene expression and genomics studies
- Clinical chemistry and biomarker reference standards — Whole blood specimens serve as matrix-matched reference materials for clinical assay development and validation
Key limitation: Human whole blood cannot be cryopreserved and must be used within hours of collection — typically within 24–48 hours for cell-based assays. This makes it unsuitable for longitudinal studies, multi-site standardization, or applications requiring banked, lot-controlled material.
Human Blood Plasma
What Is Human Plasma?
Human blood plasma is the cell-free, protein-rich liquid component of blood — the medium in which blood cells are suspended. It is obtained by centrifuging anticoagulated whole blood or a leukopak-derived fraction to pellet the cellular components, leaving the plasma supernatant. Human plasma contains water (~92%), proteins (~7% — including albumin, globulins, fibrinogen, and clotting factors), and a diverse range of small molecules including hormones, cytokines, metabolites, lipids, glucose, and electrolytes.
Two major plasma types are used in research: EDTA plasma (anticoagulated with ethylenediaminetetraacetic acid, which chelates calcium to prevent clotting) and heparin plasma (anticoagulated with heparin). The choice of anticoagulant matters for downstream applications — EDTA chelates divalent cations and can interfere with calcium-dependent assays; heparin can inhibit PCR and certain enzyme-linked assays. Citrate plasma is used specifically for platelet function and coagulation studies.
What Is Human Plasma Used For?
Human blood plasma is used as:
- Biomarker discovery substrate — Plasma proteomics, metabolomics, and cytokine profiling studies use plasma as the primary analyte-containing matrix. Its abundance of secreted proteins and signaling molecules makes it the primary liquid biopsy matrix for disease biomarker research.
- Circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) source — Human plasma contains cell-free nucleic acids shed by dying cells, including tumor-derived DNA fragments, making it the primary matrix for liquid biopsy cancer diagnostics research.
- Assay matrix matching — Antibody, ELISA, and immunoassay development requires matrix-matched calibration materials that replicate the complexity of the sample type being measured. Human plasma is used as the matrix for plasma-based clinical assay development.
- Cell culture supplement — Human plasma supplements are used in some research applications requiring serum-free but human protein-containing culture conditions.
Looking for qualified human blood products or cellular specimens?
SanguineBio supplies research-grade human PBMCs and leukopaks — as well as whole blood, plasma, serum, and other biospecimens — collected from healthy, screened donors with full characterization and same-week availability.
View PBMC Product →
View Leukopak Product →
Human Serum
What Is Human Serum?
Human serum is the cell-free, protein-rich liquid remaining after blood has been allowed to clot and the clot (containing fibrin, platelets, and clotting factors) has been removed by centrifugation. Unlike human plasma, which retains fibrinogen and other clotting factors, human serum contains no fibrinogen — it is depleted of coagulation proteins consumed during clotting. Normal human serum (from healthy, unaffected donors) is distinguished from disease-state serum used in biomarker research.
Human serum and human plasma are often confused but have distinct biochemical compositions that make them non-interchangeable for many applications. The clotting process that generates serum releases platelet-derived growth factors, cytokines stored in platelet granules, and other intracellular contents — making serum richer in certain growth factors and activated signaling molecules than plasma from the same donor. This difference is experimentally significant for any assay sensitive to these factors.
What Is Human Serum Used For?
Human serum — particularly normal human serum from healthy, screened donors — is used as:
- Blocking agent in immunoassays — Normal human serum is used to block non-specific antibody binding in ELISA, immunofluorescence, and flow cytometry assays. It saturates non-specific protein-binding sites with human proteins, reducing background from secondary antibodies raised against human Ig.
- Complement source — Serum contains fully active complement proteins. Human serum samples are used as complement sources in CDC (complement-dependent cytotoxicity) assays for antibody evaluation.
- Cell culture supplement — Human AB serum is used in T cell culture media (in place of fetal bovine serum) in applications requiring a human protein environment for primary human immune cell maintenance and expansion.
- Serology and antibody titer reference — Serum samples are the standard matrix for antibody titer measurement in vaccine immunogenicity studies, infectious disease serology, and autoantibody detection.
- Biomarker discovery — Human serum proteomics and metabolomics are used to identify disease-associated changes in secreted protein profiles. Serum is preferred over plasma for certain biomarker classes due to its enrichment in platelet-released factors.
Key fact: A serum sample from a healthy, fully characterized donor — with defined age, sex, health status, and disease-free confirmation — is a very different research material from a pooled, uncharacterized commercial serum preparation. For biomarker discovery, assay validation, or any application where donor biology is a variable, characterized individual-donor human serum is required.
Human PBMCs and Leukopaks
What Are Human PBMCs?
Human PBMCs (peripheral blood mononuclear cells) are the immune cell fraction of peripheral blood — T cells, NK cells, B cells, monocytes, and dendritic cells — isolated by density gradient centrifugation. They are the gold-standard cell preparation for T cell activation assays, cytokine profiling, NK cytotoxicity studies, vaccine immunogenicity testing, and immunomodulator drug screening. Unlike whole blood, human PBMCs can be cryopreserved, banked, and standardized across lots and sites.
SanguineBio’s human PBMCs are isolated from healthy, screened donors under controlled conditions — viability-tested, characterized, and available in fresh and cryopreserved formats.
What Are Leukopaks?
Leukopaks — leukapheresis products yielding 5–30 billion mononuclear cells per collection — are used when research applications require cell volumes that standard blood draws cannot provide: CAR-T manufacturing process development, NK cell expansion, large-scale drug screening, and high-input single-cell genomics. SanguineBio’s leukopaks are available in both fresh and cryopreserved formats from characterized donors.
CD34+ Cells: Hematopoietic Stem and Progenitor Cells
What Are CD34 Positive Cells?
CD34 positive cells — hematopoietic stem and progenitor cells (HSPCs) identified by expression of the CD34 surface antigen — are the multipotent precursor population from which all blood cell lineages arise. They are present at very low frequencies in adult peripheral blood (~0.01% of mononuclear cells in non-mobilized donors) but at substantially higher frequencies in umbilical cord blood and in mobilized peripheral blood following G-CSF or plerixafor administration.
CD34 positive cells are defined by their capacity for self-renewal and multilineage differentiation — giving rise to all myeloid (neutrophils, monocytes, dendritic cells, platelets, red blood cells) and lymphoid (T cells, B cells, NK cells) cell lineages under appropriate conditions. The CD34+ fraction of a cell preparation is the key functional specification for hematopoietic reconstitution capacity — in both clinical transplantation and preclinical humanized mouse model generation.
What Are CD34+ Cells Used For?
- Humanized mouse model generation — CD34 positive cells from cord blood or mobilized peripheral blood engraft in immunodeficient mice and reconstitute a human immune system, creating the most complete humanized model platforms available for in vivo immunology, oncology, and infectious disease research.
- Gene therapy and gene editing — The primitive differentiation state of CD34 positive cells makes them the preferred target for CRISPR-based gene correction in hematologic diseases including sickle cell disease, beta-thalassemia, and SCID. Their high transduction efficiency with lentiviral vectors and responsiveness to CRISPR RNP delivery are key properties for gene editing programs.
- Ex vivo HSPC expansion — Protocols using small molecules (StemRegenin-1, UM171) or cytokine cocktails to expand CD34+ cells ex vivo are under active development for transplantation applications requiring larger cell doses than a single cord blood unit provides.
- Hematopoietic differentiation research — CD34 positive cells are used as the starting population for in vitro differentiation into specific lineages — including NK cells, dendritic cells, megakaryocytes, and erythrocytes — for both mechanistic research and cell therapy manufacturing.
Key fact: The most accessible research-grade source of CD34 positive cells is healthy cord blood — which contains CD34+ HSPCs at substantially higher frequencies than adult peripheral blood and provides a primitive, highly engraftable progenitor population well-suited for gene editing and humanized mouse model applications. SanguineBio’s healthy cord blood is collected from screened donors and characterized for CD34+ cell content and viability.
Choosing the Right Human Blood Product for Your Research
| Research Need | Recommended Product | Key Reason |
|---|---|---|
| T cell activation, cytokine profiling, drug screening | Human PBMCs | Standardized, cryopreservable, multi-cellular context |
| CAR-T manufacturing, NK expansion, large-scale screening | Human Leukopak | Billions of cells from a single characterized donor |
| Granulocyte assays, full blood cell complexity | Human Whole Blood | Only format retaining neutrophils and full plasma |
| Biomarker discovery, proteomics, ctDNA, liquid biopsy | Human Plasma | Cell-free, retains clotting factors, preferred for cfDNA |
| Antibody titer, complement assays, cell culture supplement | Normal Human Serum | Depleted of clotting factors; active complement; Ig-rich |
| Humanized mouse models, gene therapy, HSPC research | CD34+ Cells / Cord Blood | Primitive HSPCs with high engraftment and edit efficiency |
What Makes a Human Blood Specimen Research-Grade?
Not all human blood specimens are created equal. The difference between a research-grade blood product and an uncharacterized commercial sample comes down to five parameters that every researcher sourcing blood-derived products should require from their supplier:
- Donor health confirmation — The donor should be confirmed healthy at the time of collection, off relevant medications, and free from infections or inflammatory conditions that would alter the immune composition or biochemical content of the product. For normal human serum, this is what distinguishes a true “normal” reference specimen from a sample of undetermined health status.
- Infectious disease screening — HIV-1/2, HBsAg, HCV, HTLV-I/II, syphilis, and CMV serostatus should be tested at a CLIA-certified laboratory for any human blood product intended for research use.
- Defined collection and processing documentation — Collection tube type, anticoagulant, time from draw to processing, and processing method should all be documented. These variables profoundly affect the biochemical composition of plasma, the complement activity of serum, and the functional state of cellular preparations.
- Donor metadata — Age, sex, ethnicity, BMI, fasting status (for plasma/serum metabolomics), and relevant medical history. The more defined the donor, the more the specimen can function as a controlled experimental variable rather than an uncontrolled source of noise.
- Lot-level traceability — A deidentified lot or donor ID that allows researchers to cross-reference results from different experiments run on material from the same donor — essential for multi-timepoint and multi-assay studies.
Frequently Asked Questions About Human Blood Products for Research
What is the difference between human serum and human plasma?
Human plasma is collected from anticoagulated blood and retains fibrinogen and all clotting factors. Human serum is collected after blood has clotted — the clot is removed, leaving a fibrinogen-free fluid enriched in platelet-derived growth factors and activated signaling molecules released during clotting. Neither is strictly superior; the right choice depends on your application. Serum is preferred for complement assays and serology; plasma is preferred for clotting factor studies, cfDNA extraction, and most biomarker proteomics applications.
What is normal human serum used for in research?
Normal human serum — from healthy, disease-free, characterized donors — is used as a blocking agent in immunoassays, as a complement source in CDC assays, as a human protein supplement for primary cell culture, and as a reference matrix for antibody titer and serology assay development. “Normal” specifically means the donor was confirmed healthy at collection, distinguishing the product from serum collected from individuals with active disease.
What are CD34 positive cells and where do they come from?
CD34 positive cells are hematopoietic stem and progenitor cells that give rise to all blood cell lineages. They are found in adult bone marrow, in mobilized peripheral blood (after G-CSF/plerixafor treatment), and at higher frequencies in umbilical cord blood. Cord blood is the most accessible research-grade source of primitive CD34+ cells with high engraftment potential.
Can I buy whole blood for research?
Yes. Research-grade human whole blood can be sourced from qualified biospecimen suppliers — collected into defined anticoagulant tubes, from characterized donors with full infectious disease screening. Because whole blood cannot be cryopreserved, it must be shipped fresh and used within the defined stability window for your assay application.
What human blood products does SanguineBio supply?
SanguineBio supplies research-grade human PBMCs, leukopaks, healthy cord blood, and other human biospecimens from healthy, screened donors — with full donor characterization, defined quality specifications, and same-week availability.
Summary: Key Facts About Human Blood Products for Research
- Human whole blood contains all cellular and soluble blood components — used for granulocyte assays, TLR stimulation, hematology, and platelet studies; not cryopreservable.
- Human blood plasma is the cell-free, anticoagulated liquid fraction — used for biomarker proteomics, ctDNA/cfDNA extraction, and assay matrix matching; retains clotting factors.
- Human serum (including normal human serum) is clotting-factor-depleted plasma — used for complement assays, serology, blocking reagents, and cell culture supplementation.
- Human PBMCs are the mononuclear immune cell fraction of blood — the gold-standard substrate for T cell assays, cytokine profiling, NK cytotoxicity, and drug screening.
- Leukopaks provide billions of mononuclear cells from a single donor for CAR-T manufacturing, NK expansion, and large-scale research.
- CD34 positive cells are hematopoietic stem/progenitor cells — sourced most accessibly from cord blood — used for humanized mouse models, gene therapy, and HSPC differentiation research.
- Research-grade specimens require confirmed donor health, full infectious disease screening, processing documentation, and defined donor metadata — regardless of product type.
Source qualified human blood products and biospecimens from SanguineBio.
From research-grade PBMCs and leukopaks to whole blood, plasma, serum, and cord blood — SanguineBio supplies characterized, donor-screened human specimens to support the full range of immunology, oncology, and cell therapy research applications.
Shop Human PBMCs → Shop Human Leukopaks →